BRIEF published on 11/12/2024 at 13:05, 5 months ago Yunu nomme Patrick McNamara pour accélérer sa croissance Yunu Développement Des Affaires Sciences De La Vie Patrick McNamara Imagerie D'essais Cliniques
BRIEF published on 11/12/2024 at 13:05, 5 months ago Yunu Appoints Patrick McNamara to Accelerate Growth Business Development Life Sciences Yunu Clinical Trial Imaging Patrick McNamara
PRESS RELEASE published on 11/12/2024 at 13:00, 5 months ago Yunu Welcomes Veteran Life Sciences Commercial Leader Patrick McNamara Yunu appoints Patrick McNamara as Senior VP of Business Development to drive growth initiatives in life sciences sector with expertise in clinical trial imaging workflow and data management solutions Business Development Life Sciences Yunu Clinical Trial Imaging Patrick McNamara
BRIEF published on 09/12/2024 at 13:05, 7 months ago Yunu étend l'utilisation gratuite de la plateforme du centre de cancérologie pour tous les essais cliniques du groupe d'oncologie pédiatrique Yunu Recherche Clinique Technologie D'imagerie Essais Cliniques Du COG Cancer Pédiatrique
BRIEF published on 09/12/2024 at 13:05, 7 months ago Yunu Extends Free Cancer Center Use of Platform for All Children's Oncology Group Clinical Trials Clinical Research Imaging Technology Yunu COG Clinical Trials Pediatric Cancer
PRESS RELEASE published on 09/12/2024 at 13:00, 7 months ago Yunu Extends Free Cancer Center Use of Platform for All Children’s Oncology Group Clinical Trials Yunu extends free platform use for Children's Oncology Group (COG) trials nationwide, providing world-class imaging capabilities and transforming pediatric cancer care Clinical Trials Yunu Imaging Workflow Pediatric Cancer Children's Oncology Group
BRIEF published on 07/23/2024 at 13:05, 8 months 20 days ago Taux d'erreur d'imagerie de 50 % dans les essais cliniques discutés par des panélistes d'experts de 5 centres de cancérologie désignés par le NCI Essais Cliniques Recherche Médicale Oncologie Erreurs D'imagerie Plateforme Yunu
BRIEF published on 07/23/2024 at 13:05, 8 months 20 days ago 50% Imaging Error Rate in Clinical Trials Discussed by Expert Panelists from 5 NCI-Designated Cancer Centers Clinical Trials Oncology Medical Research Imaging Errors Yunu Platform
PRESS RELEASE published on 07/23/2024 at 13:00, 8 months 20 days ago 50% Imaging Error Rate in Clinical Trials Discussed by Expert Panelists from 5 NCI-Designated Cancer Centers Panel at AACI-CRI symposium highlights concerning imaging accuracy crisis in clinical trials. Yunu's platform addresses issues, leading to significant workflow efficiencies Clinical Trials Yunu Imaging Accuracy Workflow Efficiencies AACI-CRI Symposium
BRIEF published on 05/08/2024 at 13:05, 11 months 4 days ago Yunu Introduces Advanced Imaging Workflow for Investigator-Initiated Trials Data Management Yunu Clinical Trial Imaging Cloud-based Platform Investigator-initiated Trials
Published on 04/12/2025 at 15:45, 19 hours 26 minutes ago New to The Street Announces Bloomberg Television Lineup for Saturday, April 12 at 6:30 PM ET Featuring Health In Tech CFO Julia Qian, BIOVie’s Dr. Joseph Palumbo, The Sustainable Green Team with Kevin Harrington and Tony Raynor, and eXoZymes Vice Presid
Published on 04/12/2025 at 02:00, 1 day 9 hours ago Battery X Metals Announces Provisional Patent Application with United States Patent & Trademark Office for Lithium-Ion Battery Rebalancing Technology Innovations
Published on 04/12/2025 at 00:10, 1 day 11 hours ago Applied Minerals, Inc. Files Motion to Approve Disclosure Statement
Published on 04/11/2025 at 23:45, 1 day 11 hours ago Gold Terra Closes First Tranche of Financing Package with Support from Osisko Gold Royalties
Published on 04/11/2025 at 21:45, 1 day 13 hours ago OPPO Unveils Agentic AI Initiative at Google Cloud Next 2025, Showcasing Innovations and Leadership in AI Experiences
Published on 04/11/2025 at 18:38, 1 day 16 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/11/2025 at 18:23, 1 day 16 hours ago EQS-Adhoc: Cherry SE: Cherry SE recognizes asset impairment for 2024; updates adjusted EBITDA margin for fiscal year 2024
Published on 04/11/2025 at 18:30, 1 day 16 hours ago Reclassification of shares within the Feuillet family concert with no impact on the control of the company
Published on 04/11/2025 at 18:30, 1 day 16 hours ago Reclassement d'actions au sein du concert familial Feuillet sans incidence sur le contrôle de la société
Published on 04/11/2025 at 18:00, 1 day 17 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/03/2025
Published on 04/11/2025 at 18:00, 1 day 17 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/03/2025
Published on 04/11/2025 at 17:50, 1 day 17 hours ago Mise à disposition du Rapport Financier Annuel 2024
